[Etiology and therapy of Alzheimer's disease--present status and future prospects].
Arai
H
H
Takahashi
T
T
Shibata
N
N
D000368:Aged; D000544:Alzheimer Disease / Q000209:etiology* / Q000534:rehabilitation / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D015415:Biomarkers; D001921:Brain / Q000378:metabolism / Q000473:pathology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006299:Health Services for the Aged; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D008605:Mental Health Services; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000378:metabolism; D053764:Presenilin-1; D012946:Social Welfare; D013619:Tacrine / Q000627:therapeutic use
D016229:Amyloid beta-Peptides; D015415:Biomarkers; D002800:Cholinesterase Inhibitors; D008565:Membrane Proteins; D018377:Neurotransmitter Agents; C508853:PSEN1 protein, human; D053764:Presenilin-1; D013619:Tacrine